الفهرس | Only 14 pages are availabe for public view |
Abstract Introduction: Hepatocellular carcinoma is a worldwide health problem. DAAs are recently the standard care of chronic hepatitis C infection. Many recent studies showed surprising rates of de novo and recurrent HCC after DAAs treatment whether SVR was achieved or not. Occult hepatitis B virus infection (OBI) frequently occurs in HCC patients associated with chronic hepatitis C (CHC) infection. This study aims to determine the prevalence and impact of OBI on tumor characteristics and HCC treatment outcome regarding recurrence and survival in patients with de novo HCV-related HCC after treatment with DAAs. |